Mackenzie Financial Corp Buys New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Mackenzie Financial Corp purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 629 shares of the medical research company’s stock, valued at approximately $207,000. A number of other institutional investors have also recently made changes to their positions in BIO. Venturi Wealth […]
Mackenzie Financial Corp purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 629 shares of the medical research company’s stock, valued at approximately $207,000. A number of other institutional investors have also recently made changes to their positions in BIO. Venturi Wealth […]
